E-LIB Suche - Ergebnisse für: Mittelbronn, M

1

P02.03.A INTEGRATIVE (EPI)GENETIC ANALYSIS OF INVASION-PROM..:

Müller, T ; Mittelbronn, M ; Hau, A
Neuro-Oncology. 25 (2023) Supplement_2 - p. ii29-ii30 , 2023

Link: https://doi.org/10.1093/..

2

P02.18.B INTEGRATIVE OMICS ANALYSIS OF IDH1 MUTANT GLIOMA P..:

Fritah, S ; Cano-Galiano, A ; Toth, R...
Neuro-Oncology. 25 (2023) Supplement_2 - p. ii33-ii34 , 2023

Link: https://doi.org/10.1093/..

3

Correction: Bone morphogenetic protein-7 is a MYC target wi..:

Fiaschetti, G. ; Castelletti, D. ; Zoller, S....
Oncogene. 42 (2022) 2 - p. 168-168 , 2022

Link: https://doi.org/10.1038/..

4

S137: SMALL EXTRACELLULAR VESICLES IN THE LEUKEMIA MICROENV..:

Gargiulo, E. ; Viry, E. ; Morande, P. E....
HemaSphere. 6 (2022) - p. 38-39 , 2022

Link: https://doi.org/10.1097/..

5

P10.21.B Pharmacogenomics profiling of gliomas for precisio..:

Lipsa, A ; Hau, A ; Ermini, L...
Neuro-Oncology. 24 (2022) Supplement_2 - p. ii53-ii54 , 2022

Link: https://doi.org/10.1093/..

6

OC-0322: 4-miRNA signature and MGMT promoter methylation im..:

Unger, K. ; Fleischmann, D.F. ; Ruf, V....
Radiotherapy and Oncology. 152 (2020) - p. S169-S170 , 2020

Link: https://doi.org/10.1016/..

7

OS12.2 Targeting epigenetic pathways in the treatment of re..:

Hau, A ; Houben, L ; Klein, E...
Neuro-Oncology. 21 (2019) Supplement_3 - p. iii22-iii22 , 2019

Link: https://doi.org/10.1093/..

8

P04.64Molecular characterization of glioma patient derived ..:

Golebiewska, A ; Hau, A ; Oudin, A...
Neuro-Oncology. 20 (2018) suppl_3 - p. iii294-iii294 , 2018

Link: https://doi.org/10.1093/..

9

CD74 regulates complexity of tumor cell HLA class II peptid..:

Zeiner, P. S. ; Zinke, J. ; Kowalewski, D. J....
Acta Neuropathologica Communications. 6 (2018) 1 - p. , 2018

Link: https://doi.org/10.1186/..

10

PO-0629: A 4-miRNA signature predicts the therapeutic outco..:

Niyazi, M. ; Pitea, A. ; Mittelbronn, M....
Radiotherapy and Oncology. 123 (2017) - p. S329 , 2017

Link: https://doi.org/10.1016/..

11

P03.21 Casp9 germline mutation in a family with multiple br..:

Ronellenfitsch, M. W. ; Oh, J. ; Satomi, K....
Neuro-Oncology. 19 (2017) suppl_3 - p. iii38-iii38 , 2017

Link: https://doi.org/10.1093/..

12

P01.31 Mammalian target of rapamycin complex 1 activation s..:

Thiepold, A. ; Foltyn, M. ; Urban, H....
Neuro-Oncology. 19 (2017) suppl_3 - p. iii30-iii30 , 2017

Link: https://doi.org/10.1093/..

13

P10.04 Anti-angiogenetic Therapy with Bevacizumab for Gliom..:

Burger, M. C. ; Mildenberger, I. C. ; Wagner, M...
Neuro-Oncology. 19 (2017) suppl_3 - p. iii85-iii86 , 2017

Link: https://doi.org/10.1093/..

14

P07.01 The CAR2BRAIN study: a monocentric phase I trial wit..:

Burger, M. C. ; Mildenberger, I. C. ; Cieplik, H. C....
Neuro-Oncology. 19 (2017) suppl_3 - p. iii51-iii52 , 2017

Link: https://doi.org/10.1093/..

15

OS6.4 Molecular classification of meningiomas across all hi..:

Sahm, F. ; Jones, D. T. W. ; Mittelbronn, M....
Neuro-Oncology. 18 (2016) suppl_4 - p. iv14-iv14 , 2016

Link: https://doi.org/10.1093/..